Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Rigel Pharmaceuticals, Inc. (RIGL) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$69.80M |
|
$268.06M |
|
$5.96M |
|
$63.85M |
|
$46.63M |
|
$23.17M |
|
$-0.46M |
|
$22.71M |
|
$22.71M |
|
$268.06M |
|
$268.06M |
|
$268.06M |
|
$268.06M |
|
$23.17M |
|
$23.53M |
|
17.99M |
|
18.84M |
|
$14.88 |
|
$14.11 |
|
| Balance Sheet Financials | |
$240.17M |
|
-- |
|
$273.43M |
|
$513.59M |
|
$99.24M |
|
$22.48M |
|
$22.88M |
|
$122.11M |
|
$391.48M |
|
$366.73M |
|
$391.48M |
|
18.31M |
|
| Cash Flow Statement Financials | |
$75.66M |
|
$-92.36M |
|
$0.60M |
|
$56.75M |
|
$40.64M |
|
$-16.11M |
|
$12.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.42 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.05 |
|
0.13 |
|
91.47% |
|
33.19% |
|
33.19% |
|
-- |
|
32.54% |
|
384.04% |
|
$75.66M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.52 |
|
1.35 |
|
66.74 |
|
68.47% |
|
73.10% |
|
52.19% |
|
64.76% |
|
$21.38 |
|
$4.02 |
|
$4.02 |
|